Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1684-1689

  Walker, Lynn C ^b   Venglarik, Charles J ^b   Aubin, Gervais ^b   Weatherly, Mark R ^b   McCarty, Nael A ^b   Lesnick, Burt ^b   Ruiz, Fadel ^b   Clancy, John P ^b   Sorscher, Eric J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORIDE ION; ISOPRENALINE; RINGER LACTATE SOLUTION; SODIUM ION; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; BIOENERGY; CELL STRAIN COS1; CHILD; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE TRANSFER; HUMAN; ION TRANSPORT; LUNG DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SODIUM TRANSPORT;

EID: 0030960151     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154877     Document Type: Article

References (34)

1. Registry. 1994. North American Cystic Fibrosis Foundation, Bethesda, MD.
2. Gan, K. H., H. G. M. Heijerman, and W. Bakker. 1994. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 330:865-866.
3. Gan, K. H., H. J. Veeze, A. M. van den Ouweland, D. J. Halley, H. Scheffer, A. van der Hout, S. E. Overbeek, J. C. de Jongste, W. Bakker, and H. G. Heijerman. 1995. A cystic fibrosis mutation associated with mild lung disease. N. Engl. J. Med. 333:95-99.
4. Kristidis, P., D. Bozon, M. Corey, D. Markiewicz, J. Rommens, L. C. Tsui, and P. Durie. 1992. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50:1178-1184.
5. Veeze, H. J., D. J. Halley, J. Bijman, J. C. de Jongste, H. R. de Jonge, and M. Sinaasappel. 1994. Determinants of mild clinical symptoms in cystic fibrosis patients. J. Clin. Invest. 93:461-466.
6. van Biezen, P., S. E. Overbeek, and C. Hilvering. 1992. Cystic fibrosis in a 70-year-old woman. Thorax 47:202-203.
7. Sheppard, D. N., L. S. Ostedgaard, M. C. Winter, and M. J. Welsh. 1995. Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency. EMBO J. 14:876-883.
8. Tsui, L.-C. 1992. The spectrum of cystic fibrosis mutations. Trends Genet. 8:392-398.
9. Cuppens, H., P. Marynen, C. De Boeck, F. De Baets, E. Eggermont, H. Van den Berghe, and J. J. Cassiman. 1990. A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew. J. Med. Genet. 27:717-719.
10. Cutting, G. R., L. M. Kasch, B. J. Rosenstein, L. C. Tsui, H. H. Kazazian, Jr., and S. E. Antonarakis. 1990. Two patients with cystic fibrosis, non-sense mutations in each cystic fibrosis gene, and mild pulmonary disease. N. Engl. J. Med. 323:1685-1689.
11. Hamosh, A., and M. Corey. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 329:1308-1313.
12. Liechti-Gallati, S., I. Bonsall, N. Malik, V. Schneider, L. G. Kraemer, A. Ruedeberg, H. Moser, and R. Kraemer. 1992. Genotype-phenotype association in cystic fibrosis: analyses of the AF508, R553X, and 3905insT mutations. Pediair. Res. 32:175-178.
13. Dork, T., U. Wulbrand, T. Richter, T. Neumann, H. Wolfes, B. Wulf, G. Maass, and B. Tummler. 1991. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum. Genet. 87:441-446.
14. Hamosh, A., B. C. Trapnell, P. L. Zeitlin, C. Montrose-Rafizadeh, B. J. Rosenstein, R. G. Crystal, and G. R. Cutting. 1991. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J. Clin. Invest. 88: 1880-1885.
15. Hamosh, A., B. J. Rosenstein, and G. R. Cutting. 1992. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum. Mol. Genet. 1:542-544.
16. Knowles, M. R., A. M. Paradiso, and R. C. Boucher. 1995. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther. 6:445-455.
17. Sauder, R. A., S. E. Chesrown, and G. M. Loughlin. 1987. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J. Pediatr. 111:353-358.
18. Alton, E. W. F. W., D. Currie, R. Logan-Sinclair, J. O. Warner, M. E. Hodson, and D. M. Geddes. 1990. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur. Respir. J. 3:922-926.
19. Caplen, N. J., E. W. F. W. Alton, P. G. Middleton, J. R. Dorin, B. J. Stevenson, X. Gao, S. R. Durham, P. K. Jeffery, M. E. Hodson, C. Coutelle, L. Huang, D. J. Porteous, R. Williamson, and D. M. Geddes. 1995. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1:39-46.
20. Highsmith, W. E., L. H. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittel, K. J. Friedman, L. M. Silverman, R. C. Boucher, and M. R. Knowles. 1994. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but with normal sweat chloride concentration. N. Engl. J. Med. 331:974-980.
21. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C. S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8:42-51.
22. Rozen, R., M. De Braekeleer, J. Daigneault, L. Ferreira-Rajabi, M. Gerdes, L. Lamoureux, G. Aubin, F. Simard, T. M. Fujiwara, and K. Morgan. 1992. Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am. J. Med. Genet. 42:360-364.
23. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature 348:91-92.
24. Cheng, S. H., R. J. Gregory, J. Marshall, S. Paul, D. W. Souza, G. A. White, C. R. Riordan, and A. E. Smith. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:827-834.
25. Anderson, M. P., D. P. Rich, R. J. Gregory, A. E. Smith, and M. J. Welsh. 1991. Generation of cAMP-activated chloride currents by expression of CFTR. Science 251:679-682.
26. - channel. Cell 76:1091-1098.
27. Rich, D. P., R. J. Gregory, M. P. Anderson, P. Manavalan, A. E. Smith, and M. J. Welsh. 1991. Effect of deleting the R domain on CFTR-generated chloride channels. Science 253:205-207.
28. Sorscher, E. J., K. Kirk, M. L. Weaver, T. Jilling, J. E. Blalock, and R. D. LeBouef. 1991. Antisense oligodeoxynucleotide to the cystic fibrosis gene inhibits anion transport in normal cultured sweat ducts. Proc. Natl. Acad. Sci. U.S.A. 88:7759-7762.
29. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993, Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.
30. Knowles, M. R., K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L. Noah, P. C. Hu, M. W. Leigh, J. F. Engelhardt, L. J. Edwards, K. R. Jones, M. Grossman, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1995. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333: 823-831.
31. Rozmahel, R., M. Wilschanski, A. Matin, S. Plyte, M. Oliver, W. Auerbach, A. Moore, J. Forstner, P. Durie, J. Nadeau, C. Bear, and L. C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12:280-287.
32. Clarke, L. L., B. R. Grubb, J. R. Yankaskas, C. U. Cotton, A. McKenzie, and R. C. Boucher. 1994. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in CFTR (-/-) mice. Proc. Natl. Acad. Sci. U.S.A. 91:479-483.
33. Sorscher, E. J., and J. J. Logan. 1994. Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway. Hum. Gene Ther. 5:1259-1299.
34. - secretion in epithelial cells. Am. J. Physiol. 266 (Cell Physiol. 35):C254-C268.